« Back to Record
Citation APA

Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., Adriaens, C., Radaelli, E., Wolter, P., Bechter, O., Dummer, R., Levesque, M. P., Piris, A., Frederick, D. T., Boland, G., Flaherty, K. K., van den Oord, J., Voet, T., Aerts, S., Lund, A. A., & Marine, J.-C. (2018). Toward Minimal Residual Disease-Directed Therapy in Melanoma. Cell, 174(4), 843-855.e19. doi:10.1016/j.cell.2018.06.025


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/402046

Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., Adriaens, C., Radaelli, E., Wolter, P., Bechter, O., Dummer, R., Levesque, M. P., Piris, A., Frederick, D. T., Boland, G., Flaherty, K. K., van den Oord, J., Voet, T., Aerts, S., Lund, A. A., & Marine, J.-C. (2018). Toward Minimal Residual Disease-Directed Therapy in Melanoma. Cell, 174(4), 843-855.e19. doi:10.1016/j.cell.2018.06.025